Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5UBM

Crystal structure of human C1s in complex with inhibitor gigastasin

5UBM の概要
エントリーDOI10.2210/pdb5ubm/pdb
分子名称Complement C1s subcomponent, Gigastasin, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total)
機能のキーワードcomplement system c1s protease inhibitor complex, immune system-inhibitor complex, immune system/inhibitor
由来する生物種Haementeria ghilianii
詳細
タンパク質・核酸の鎖数3
化学式量合計61253.12
構造登録者
Pang, S.S.,Whisstock, J.C. (登録日: 2016-12-20, 公開日: 2017-11-08, 最終更新日: 2024-11-06)
主引用文献Pang, S.S.,Wijeyewickrema, L.C.,Hor, L.,Tan, S.,Lameignere, E.,Conway, E.M.,Blom, A.M.,Mohlin, F.C.,Liu, X.,Payne, R.J.,Whisstock, J.C.,Pike, R.N.
The Structural Basis for Complement Inhibition by Gigastasin, a Protease Inhibitor from the Giant Amazon Leech.
J. Immunol., 199:3883-3891, 2017
Cited by
PubMed Abstract: Complement is crucial to the immune response, but dysregulation of the system causes inflammatory disease. Complement is activated by three pathways: classical, lectin, and alternative. The classical and lectin pathways are initiated by the C1r/C1s (classical) and MASP-1/MASP-2 (lectin) proteases. Given the role of complement in disease, there is a requirement for inhibitors to control the initiating proteases. In this article, we show that a novel inhibitor, gigastasin, from the giant Amazon leech, potently inhibits C1s and MASP-2, whereas it is also a good inhibitor of MASP-1. Gigastasin is a poor inhibitor of C1r. The inhibitor blocks the active sites of C1s and MASP-2, as well as the anion-binding exosites of the enzymes via sulfotyrosine residues. Complement deposition assays revealed that gigastasin is an effective inhibitor of complement activation in vivo, especially for activation via the lectin pathway. These data suggest that the cumulative effects of inhibiting both MASP-2 and MASP-1 have a greater effect on the lectin pathway than the more potent inhibition of only C1s of the classical pathway.
PubMed: 29061764
DOI: 10.4049/jimmunol.1700158
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.5 Å)
構造検証レポート
Validation report summary of 5ubm
検証レポート(詳細版)ダウンロードをダウンロード

248942

件を2026-02-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon